Curative Biotechnology, Inc. (CUBT)
USD 0.01
(-13.64%)
USD 0.01
(-13.64%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.25 Million USD | 110.94% |
| 2022 | 1.07 Million USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 559.76 Thousand USD | 448426.44% |
| 2019 | 124.80 USD | -99.94% |
| 2018 | 198.76 Thousand USD | 0.08% |
| 2017 | 198.61 Thousand USD | 0.08% |
| 2016 | 198.46 Thousand USD | 0.27% |
| 2015 | 197.94 Thousand USD | -20.71% |
| 2014 | 249.64 Thousand USD | -4.26% |
| 2013 | 260.74 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 2.23 Million USD | -1.06% |
| 2024 Q2 | 2.46 Million USD | 10.42% |
| 2023 Q2 | 1.39 Million USD | 1.8% |
| 2023 Q3 | 1.43 Million USD | 3.26% |
| 2023 Q1 | 1.36 Million USD | 27.86% |
| 2023 FY | 2.25 Million USD | 110.94% |
| 2023 Q4 | 2.25 Million USD | 56.94% |
| 2022 Q2 | 580.95 Thousand USD | 272.57% |
| 2022 Q4 | 1.07 Million USD | 26.47% |
| 2022 Q3 | 846.54 Thousand USD | 45.72% |
| 2022 FY | 1.07 Million USD | 0.0% |
| 2022 Q1 | 155.93 Thousand USD | 0.0% |
| 2021 Q1 | 43.93 Thousand USD | -92.15% |
| 2021 FY | - USD | -100.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q3 | - USD | -100.0% |
| 2021 Q2 | 130.64 Thousand USD | 197.34% |
| 2020 Q4 | 559.76 Thousand USD | 1064.16% |
| 2020 Q1 | 14.53 Thousand USD | 0.0% |
| 2020 Q2 | 31.73 Thousand USD | 118.37% |
| 2020 FY | 559.76 Thousand USD | 448426.44% |
| 2020 Q3 | 48.08 Thousand USD | 51.52% |
| 2019 Q4 | - USD | 0.0% |
| 2019 FY | 124.80 USD | -99.94% |
| 2018 FY | 198.76 Thousand USD | 0.08% |
| 2017 FY | 198.61 Thousand USD | 0.08% |
| 2016 FY | 198.46 Thousand USD | 0.27% |
| 2015 FY | 197.94 Thousand USD | -20.71% |
| 2014 Q1 | 255.71 Thousand USD | -1.93% |
| 2014 FY | 249.64 Thousand USD | -4.26% |
| 2013 Q1 | 176.92 Thousand USD | 0.0% |
| 2013 Q4 | 260.74 Thousand USD | 0.0% |
| 2013 FY | 260.74 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 43.37 Million USD | 94.793% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -258.429% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | 95.043% |
| Adynxx, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -1743.576% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -541.865% |
| Rebus Holdings, Inc. | 310 Thousand USD | -628.51% |
| Skye Bioscience, Inc. | 4.61 Million USD | 51.067% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | 92.413% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -8680.983% |
| Arch Therapeutics, Inc. | 5.87 Million USD | 61.534% |
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | 94.519% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | 45.211% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -461.997% |
| SQZ Biotechnologies Company | 27.47 Million USD | 91.779% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | 2.905% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -138.158% |
| Mesoblast Limited | 118.7 Million USD | 98.097% |
| Marizyme, Inc. | 18.71 Million USD | 87.934% |
| Genus plc | 233.1 Million USD | 99.031% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | 22.932% |
| Pharming Group N.V. | 171.54 Million USD | 98.684% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -154.304% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -68.086% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -201.117% |
| ContraFect Corporation | 2.88 Million USD | 21.611% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -1566.862% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -56.147% |
| IMV Inc. | 28.88 Million USD | 92.181% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | 60.088% |
| MultiCell Technologies, Inc. | 202.58 USD | -1114709.458% |
| ONE Bio Corp. | 19.71 Million USD | 88.545% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | 96.072% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.49 Million USD | -51.087% |
| Q BioMed Inc. | 4.1 Million USD | 45.051% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | 93.177% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -83.853% |
| Biomind Labs Inc. | 735.54 Thousand USD | -207.036% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | 96.661% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | 25.372% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | 82.624% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -527.834% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -1495.826% |
| GB Sciences, Inc. | 1.75 Million USD | -28.368% |
| Alpha Cognition Inc. | 1.22 Million USD | -85.057% |
| HST Global, Inc. | 98.31 Thousand USD | -2196.993% |
| CSL Limited | 12.18 Billion USD | 99.981% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -808.001% |
| Halberd Corporation | 150 Thousand USD | -1405.587% |
| Enzolytics Inc. | 996.33 Thousand USD | -126.668% |
| Agentix Corp. | 50 Thousand USD | -4416.762% |
| Resverlogix Corp. | 6.49 Million USD | 65.208% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -783.588% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 20 Million USD | 88.708% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 68.07% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 16.625% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -21986.856% |
| Genscript Biotech Corporation | 417.73 Million USD | 99.459% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -1025.723% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | 5.811% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -884.941% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -1419.22% |
| Kadimastem Ltd | 891.22 Thousand USD | -153.402% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | 88.89% |
| BioStem Technologies, Inc. | 4.71 Million USD | 52.066% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -802.695% |
| LadRx Corporation | 33.6 Thousand USD | -6620.172% |
| Cell Source, Inc. | 9.25 Million USD | 75.596% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -198.647% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -198.647% |
| NovAccess Global Inc. | 2.19 Million USD | -2.659% |
| Affymax, Inc. | - USD | -Infinity% |
| Itoco Inc. | 228.37 Thousand USD | -888.883% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -970.45% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | 54.678% |
| Mobile Lads Corp. | 484.28 Thousand USD | -366.334% |
| CytoDyn Inc. | 30.07 Million USD | 92.491% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | 71.12% |
| SYBLEU INC | 477.5 Thousand USD | -372.959% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | 52.307% |
| International Stem Cell Corporation | 4.17 Million USD | 45.946% |
| Bioxytran, Inc. | 1.92 Million USD | -17.318% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -3518.446% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -3.553% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | 72.843% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | 73.694% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -45.189% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -742.679% |
| Neutra Corp. | 54.15 Thousand USD | -4070.14% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -23.409% |
| PureTech Health plc | 25.51 Million USD | 91.148% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -84.474% |
| IXICO plc | 472.02 Thousand USD | -378.447% |
| IntelGenx Technologies Corp. | 15.5 Million USD | 85.431% |
| Gelesis Holdings, Inc. | 62.26 Million USD | 96.373% |
| CSL Limited | 12.18 Billion USD | 99.981% |
| Cellectis S.A. | 92.77 Million USD | 97.566% |